KTTANasdaqPharmaceutical PreparationsFiscal year ends December 31
Pasithea Therapeutics Corp.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.41−0.01 (-1.83%)
Close on Oct 19, 2026
- Market cap
- $13.23M
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Pasithea Therapeutics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Sep 16, 2026 | Sep 16, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 9, 2026 | Sep 9, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 20, 2026 | Aug 21, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 14, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Sep 9, 2026 | Aug 7, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 15, 2026 | SEC EDGAR |
| Current report | 8-K | May 1, 2026 | May 4, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Mar 30, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 20, 2026 | Feb 20, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 28, 2026 | Jan 28, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Jan 28, 2026 | Dec 29, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 12, 2025 | Dec 15, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 28, 2025 | Dec 2, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 20, 2025 | Nov 25, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 13, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 4, 2025 | Nov 4, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 24, 2025 | Oct 27, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 16, 2025 | Sep 16, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 3, 2025 | Sep 3, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 14, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Sep 3, 2025 | Jul 24, 2025 | SEC EDGAR |
| Current report | 8-K | Jul 10, 2025 | Jul 11, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 23, 2025 | Jun 27, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 20, 2025 | Jun 20, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 15, 2025 | SEC EDGAR |
| Current report | 8-K | May 6, 2025 | May 7, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 23, 2025 | Apr 25, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Mar 24, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 26, 2024 | Nov 26, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 13, 2024 | SEC EDGAR |
| Current report | 8-K | Sep 26, 2024 | Sep 30, 2024 | SEC EDGAR |
| Current report | 8-K | Sep 26, 2024 | Sep 26, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Aug 13, 2024 | SEC EDGAR |
| Current report | 8-K | Jun 26, 2024 | Jun 26, 2024 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 26, 2024 | May 28, 2024 | SEC EDGAR |
| Current report | 8-K | May 13, 2024 | May 14, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2024 | May 14, 2024 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2023 | Mar 29, 2024 | SEC EDGAR |
| Current report | 8-K | Jan 17, 2024 | Jan 18, 2024 | SEC EDGAR |
| Current report | 8-K | Dec 29, 2023 | Jan 2, 2024 | SEC EDGAR |